Representative before the EPO

Employment test 11 - 50 employees
Company dna reitstotter kinzebach and partner
operating since 1928
Headquarter in Munich, Berlin and 1 office
active in Legal Services

We have observed 2 EP applications Thomas Wolter has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 28, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13185422

Compositions monovalent for CD28 binding and methods of use

IPC classification:
C07K 16/28
Applicant:
Bristol-Myers Squibb Company
Agent:
Thomas Wolter, Reitstötter Kinzebach & Partner GbR
Status:
GRANT OF PATENT INTENDED
EP14802476

NMDA ANTAGONIST PRODRUGS

IPC classification:
A61K 31/4402, A61K 31/4439, A61P 25/24, C07D 213/40, C07D 401/12, C07D 401/14
Applicant:
AstraZeneca AB
Agent:
Thomas Wolter, Reitstötter Kinzebach & Partner GbR
Agent:
Diana Jean Pisani, Ropes & Gray International LLP
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature